Trials / Conditions / Biochemical Recurrent Prostate Cancer
Biochemical Recurrent Prostate Cancer
3 registered clinical trials studyying Biochemical Recurrent Prostate Cancer.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | MBM-02 (Tempol) for the Treatment of Biochemical Recurrent Prostate Cancer NCT04876755 | Matrix Biomed, Inc. | Phase 2 |
| Active Not Recruiting | Radium-223 in Biochemically Recurrent Prostate Cancer NCT04206319 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Isoflavone in Prostate-specific Antigen Recurrent Prostate Cancer NCT00596895 | University of Florida | Phase 2 |